Literature DB >> 2399337

Extracranial carotid arteries: evaluation with "black blood" MR angiography.

R R Edelman1, H P Mattle, B Wallner, R Bajakian, J Kleefield, C Kent, J J Skillman, J B Mendel, D J Atkinson.   

Abstract

The authors evaluated the accuracy of "black blood" magnetic resonance (MR) angiography for depicting disease involving the extracranial carotid arteries. Two- and three-dimensional flow-compensated gradient-echo sequences were employed to create "bright blood" images. A thin-section spin-echo sequence with flow presaturation allowed the creation of black blood images. Projection angiograms were made from bright and black blood images with application of a maximum- or minimum-intensity projection algorithm, respectively. These methods were used in 13 healthy volunteers and 17 patients, and a prospective blinded comparison of MR angiography and conventional angiography was performed. Normal carotid arteries were well shown with both bright and black blood methods; in patients, both methods were sensitive for detecting carotid disease. However, bright blood angiography exaggerated the severity of carotid lesions in 13 of 33 arteries, mostly in severe disease; this problem was not encountered with black blood angiography. The authors conclude that bright blood angiography is a sensitive method for screening carotid disease; when a significant abnormality is found, black blood angiography should be performed for more precise delineation of the lesion.

Entities:  

Mesh:

Year:  1990        PMID: 2399337     DOI: 10.1148/radiology.177.1.2399337

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  24 in total

1.  Magnetic resonance angiography of extracranial carotid and vertebral arteries, including their origins: comparison with digital subtraction angiography.

Authors:  Y Furuya; H Isoda; S Hasegawa; M Takahashi; M Kaneko; K Uemura
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

2.  A noncontrast-enhanced pulse sequence optimized to visualize human peripheral vessels.

Authors:  Kjell-Inge Gjesdal; Tryggve Storaas; Jonn-Terje Geitung
Journal:  Eur Radiol       Date:  2008-08-15       Impact factor: 5.315

3.  3D MR angiography with ramp-shaped flip-angle distribution.

Authors:  J Martos; T Nägele; U Klose; D Petersen; K Voigt
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

4.  Time of Flight 3D Magnetic Resonance Angiography in the Follow-up of Coiled Cerebral Aneurysms.

Authors:  W M Adams; R D Laitt; A Jackson
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

5.  Enhanced image quality in black-blood MRI using the improved motion-sensitized driven-equilibrium (iMSDE) sequence.

Authors:  Jinnan Wang; Vasily L Yarnykh; Chun Yuan
Journal:  J Magn Reson Imaging       Date:  2010-05       Impact factor: 4.813

Review 6.  Intracranial Vessel Wall MRI: Principles and Expert Consensus Recommendations of the American Society of Neuroradiology.

Authors:  D M Mandell; M Mossa-Basha; Y Qiao; C P Hess; F Hui; C Matouk; M H Johnson; M J A P Daemen; A Vossough; M Edjlali; D Saloner; S A Ansari; B A Wasserman; D J Mikulis
Journal:  AJNR Am J Neuroradiol       Date:  2016-07-28       Impact factor: 3.825

7.  CINE turbo spin echo imaging.

Authors:  Jason Mendes; Dennis L Parker; Jordan Hulet; Gerald S Treiman; Seong-Eun Kim
Journal:  Magn Reson Med       Date:  2011-06-23       Impact factor: 4.668

Review 8.  Imaging biomarkers of cardiovascular disease.

Authors:  Jinnan Wang; Niranjan Balu; Gador Canton; Chun Yuan
Journal:  J Magn Reson Imaging       Date:  2010-09       Impact factor: 4.813

Review 9.  Medical imaging.

Authors:  L Kreel
Journal:  Postgrad Med J       Date:  1991-04       Impact factor: 2.401

10.  Surface appearance of the vertebrobasilar artery revealed on basiparallel anatomic scanning (BPAS)-MR imaging: its role for brain MR examination.

Authors:  Morio Nagahata; Yoshinao Abe; Shuichi Ono; Takaaki Hosoya; Seiyu Uno
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.